nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

Glenmark Pharmaceuticals Limited (NSE India Code : GLENMARK) BUY

Company Name :

Enter Company Name or NSE Code

GLENMARK Technical Levels

Resistance 2		424.35
Resistance 1		421.90
PIVOT		419.50
Support 1		417.05
Support 2		412.20

GLENMARK Fundamentals

Earning Growth		-48.25%
Profit Margin		14.45
PE		54.22
EPS		7.01
Quarter		30-Sep-11

GLENMARK Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size

GLENMARK Options

Most Active Call
Most Active Put
Highest OI Call
Highest OI Put
Expiry Date

GLENMARK Technical Levels

Other Stocks from Pharmaceuticals Sector AARTIDRUGS ABBOTINDIA AJANTPHARM ALCHEM ALKALI ALPA AMRUTANJAN ANKURDRUGS ARL ASTRAZEN AUROPHARMA AVENTIS BALPHARMA BIOCON BLISSGVS CADILAHC CELESTIAL CIPLA DISHMAN DIVISLAB DRREDDY ELDERPHARM FDC FKONCO GLAXO GLENMARK GRANULES INDOCO INDSWFTLAB INDSWFTLTD IPCALAB JAGSNPHARM JBCHEPHARM JUBILANT KILITCH KOPRAN LUPIN LYKALABS MANGALAM MERCK MOREPENLAB NATCOPHARM NECLIFE NEULANDLAB OPTOCIRCUI ORCHIDCHEM PANACEABIO PARABDRUGS PFIZER PIRHEALTH

Sponsored Advertisement

GLENMARK Share Price on 5-10-2012

Open		407.05
High		411.9
Low		387
Close		399.95
Volume		485847
Change		-7.05 (-1.73%)

Series		EQ
Date of Listing		07-Feb-00
Paid Up Value		1
Face Value		1
Market Capital		5601.93 Crores
52 Week High/Low		450 / 264.75

Sponsored Advertisement

Glenmark Pharmaceuticals Limited Company Profile

Glenmark Pharmaceuticals (GPL) is engaged in the research and development, manufacturing and marketing of branded formulations in India and abroad. The company is headquartered at Mumbai and was incorporated in the year 1977 by Gracias Saldanha. Its business segments include India API, exports formulations and API NCE research. The company is present in over 80 countries across the globe, with some of its subsidiaries and representative offices in the United States, the United Kingdom, Switzerland, Brazil, South Africa, Nigeria, Russia, Philippines and Malaysia. It has been involved in new drug discoveries such as new molecules for asthma, obesity and diabetes segments. Glenmark has been involved in API business. Glenmark conducts its operations through its manufacturing plants including Baddi, Goa, Nasik and Sao Paulo, Brazil for formulations and Ankleshwar, Kurkumbh and Solapur for API. Glenmark Pharmaceuticals` research activities encompass process engineering for APIs, new chemical entity research and novel drug delivery systems [NDDS]. The company also operates a second research facility at Sinnar, India that focuses on developing formulations for India and markets across Asia, Africa, Latin America and CIS/Russia. The company is further researching PDE-4 inhibitors for CNS indications, cognitive disorders and inflammatory conditions such as atopic dermatitis, ulcerative colitis and rheumatoid arthritis. Other research areas include diabetes segment in which the company has a DPP-IV target, GRC 8200, in Phase I clinical trials. For the last five years the company has increased its growth through investment in dedicated research and development, including cutting-edge New Chemical Technology (NCE) research. The company currently ranks among the top 20 Indian pharmaceutical firms.

GLENMARK Intraday Realtime Chart

GLENMARK Corporate Announcements

DATE	PURPOSE
06-Aug-12	Press Release
02-Aug-12	Allotment of Securities
02-Aug-12	Press Release
02-Aug-12	Financial Result Updates
19-Jun-12	Allotment of Securities

GLENMARK Corporate Actions

DATE	PURPOSE
19-Jul-12	Annual General Meeting / Dividend Rs 2 Per Share
19-Jul-12	AGM/DIV RS 2 PER SHARE
28-Jul-11	Annual General Meeting And Dividend Re.0.40 Per Share
28-Jul-11	AGM/DIV-RE.0.40 PER SHARE

GLENMARK Board Meetings

MEETING DATE	PURPOSE
02-Aug-12	Financial Results
08-May-12	Results/Dividend
30-Jan-12	Un-audited Financial Results
09-Nov-11	Un-audited Financial Results
26-Jul-11	Un-audited Financial Results

GLENMARK Related companies

Symbol	Company Name
AARTIDRUGS	Aarti Drugs Limited
ABBOTINDIA	Abbott India Limited
AJANTPHARM	Ajanta Pharma Limited
ALCHEM	Alchemist Limited
ALKALI	Alkali Metals Limited

Most Active NSE INDIA Stocks

HDFC LITL IVRCLINFRA HDIL UNITECH JPASSOCIAT GVKPIL TATAMOTORS IFCI IBREALEST ESSAROIL GMRINFRA BIRLAPOWER HINDALCO BHEL RENUKA RCOM DLF SUZLON RELCAPITAL IDFC ADANIENT ITC TATAPOWER BALLARPUR

Free Stock Market Tips:

What are the products dealt in the secondary markets?

Home	Stock Market	IPO	Mutual Funds	Education	Paid Service
About us	Share Market	IPO Watch	MF News	IPO	Subscription
VJonDalalStreet	Technical Analysis	New IPO Review	Old Funds	Articles	Equity Performance
DalalStreet Blog	Stock Market News	Indian IPO News	New Funds	Stock Market	Futures Performance
Free Sms Alerts	World Stock Market	IPO Allotment Status	Best Funds	Financial Terms	Options Performance
Privacy	Stock Recommendations	Grey Market Premium	MF Analysis	Futures & Options	Jackpot Performance

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer